GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® ...
November 18, 2025—RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial intelligence (AI) solution for acute assessment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback